Skip to main content

Specialty Pharmacy

  • 8th annual Armada Specialty Pharmacy Summit sees 30% boost in attendance

    LAS VEGAS — The 8th annual Armada Specialty Pharmacy Summit officially kicked off here at the Wynn casino resort on Wednesday morning, with early attendance figures showing a 30% increase over 2011, when more than 1,500 executives attended.

  • FDA approves Pfizer, Protalix drug for Gaucher disease

    NEW YORK — The Food and Drug Administration has approved a new treatment for a rare genetic disorder that affects 10,000 people worldwide.

    Pfizer and Protalix BioTherapeutics announced Wednesday the approval of Elelyso (taliglucerase alfa), an enzyme-replacement therapy for the long-term treatment of Type 1 Gaucher disease.

  • Reports: Dying woman's plea prompts early release of cancer drug

    NEW YORK — An online plea for help from a mother dying of breast cancer prompted the manufacturer of an experimental drug to release it early, according to published reports.

    In an article posted on its website, CNN told the story of 46-year-old Darlene Gant, a woman with stage-four breast cancer, as she wrote letters to be given to her 11-year-old son on his upcoming birthday, and at future events, such as his high school and college graduations and marriage.

  • FDA approves Novartis drug for tumors in patients with rare genetic disease

    EAST HANOVER, N.J. — A drug made by Novartis has received approval from the Food and Drug Administration to treat benign kidney tumors related to tuberous sclerosis complex.

    The FDA approved Afinitor (everolimus) tablets for treating the tumors, known as renal angiomyolipomas, in adults with TSC who don't require surgery. The drug already was approved to treat brain tumors known as subependymal giant cell astrocytoma, or SEGA, in patients with TSC.

  • Vaccines in development could open opportunity for specialty pharmacies

    WHAT IT MEANS AND WHY IT'S IMPORTANT — Since the development of the first smallpox vaccine in 1796, vaccines have saved countless lives around the world and helped to make such deadly scourges as smallpox and polio things of the past.

    (THE NEWS: PhRMA report lists almost 300 vaccines under development. For the full story, click here.)

  • FDA approves GlaxoSmithKline's Votrient for soft tissue sarcomas

    PHILADELPHIA — The Food and Drug Administration has approved a drug made by GlaxoSmithKline for certain cancer patients.

  • Study: Walgreens home infusion service may deliver services faster than an ER visit

    PHOENIX — Patients with a rare, life-threatening genetic immune system disorder can receive treatment for sudden episodes more quickly and cost-effectively at home than if they go to the emergency room, according to a Walgreens Infusion Services study being presented Wednesday at the National Home Infusion Association Annual Conference and Exposition here.

  • PhRMA report lists almost 300 vaccines under development

    WASHINGTON — Drug makers in the United States are developing nearly 300 vaccines for preventing and treating diseases, according to a new report by a drug industry trade group.

X
This ad will auto-close in 10 seconds